Indeed, low levels of GH and IGF-1 were generally associated with a higher degree of fibrosis, steatosis, hepatic inflammation, and hepatocellular injury, the four main components responsible for the progressive development of NASH from NAFLD [2,6] (Figure 3). The gene discussed is GH1; the disease is metabolic dysfunction-associated steatotic liver disease.